ask="81.00"
ask_size="1500"
average_daily_volume="602695"
bid="55.00"
bid_size="4900"
book_value="11.38"
change="-2.20"
change_from_200_day_moving_average="8.18"
change_from_50_day_moving_average="-0.47"
change_from_52_week_high="-19.63"
change_From_52_week_low="28.25"
change_in_percent="-2.86%"
close="74.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="77.76"
high_52_weeks="94.40"
last_trade_date="1/9/2017"
last_trade_price="74.77"
last_trade_size="31970"
last_trade_time="4:00pm"
low="74.21"
low_52_weeks="46.52"
market_capitalization="3.06B"
moving_average_200_day="66.59"
moving_average_50_day="75.24"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="77.21"
pe_ratio="N/A"
peg_ratio="-0.42"
percent_change_from_200_day_moving_average="+12.29%"
percent_change_from_50_day_moving_average="-0.62%"
percent_change_from_52_week_high="-20.79%"
percent_change_from_52_week_low="+60.73%"
previous_close="76.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.76"
price_per_sales="24569.67"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="603297"
weeks_range_52="46.52 - 94.40"
